194 related articles for article (PubMed ID: 14533197)
1. Functional delivery of large genomic DNA to human cells with a peptide-lipid vector.
White RE; Wade-Martins R; Hart SL; Frampton J; Huey B; Desai-Mehta A; Cerosaletti KM; Concannon P; James MR
J Gene Med; 2003 Oct; 5(10):883-892. PubMed ID: 14533197
[TBL] [Abstract][Full Text] [Related]
2. Biophysical characterization of an integrin-targeted non-viral vector.
Lee LK; Siapati EK; Jenkins RG; McAnulty RJ; Hart SL; Shamlou PA
Med Sci Monit; 2003 Jan; 9(1):BR54-61. PubMed ID: 12552238
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of integrin-mediated transfection of haematopoietic cells with a synthetic vector system.
Uduehi A; Mailhos C; Truman H; Thrasher AJ; Kinnon C; Hart SL
Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):201-9. PubMed ID: 12812522
[TBL] [Abstract][Full Text] [Related]
4. Non-viral, integrin-mediated gene transfer into fibroblasts from patients with lysosomal storage diseases.
Estruch EJ; Hart SL; Kinnon C; Winchester BG
J Gene Med; 2001; 3(5):488-97. PubMed ID: 11601762
[TBL] [Abstract][Full Text] [Related]
5. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.
Cemazar M; Sersa G; Wilson J; Tozer GM; Hart SL; Grosel A; Dachs GU
Cancer Gene Ther; 2002 Apr; 9(4):399-406. PubMed ID: 11960291
[TBL] [Abstract][Full Text] [Related]
6. Stable integration of large (>100 kb) PAC constructs in HaCaT keratinocytes using an integrin-targeting peptide delivery system.
Compton SH; Mecklenbeck S; Mejía JE; Hart SL; Rice M; Cervini R; Barrandon Y; Larin Z; Levy ER; Bruckner-Tuderman L; Hovnanian A
Gene Ther; 2000 Sep; 7(18):1600-5. PubMed ID: 11021599
[TBL] [Abstract][Full Text] [Related]
7. Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector.
Hart SL; Arancibia-Cárcamo CV; Wolfert MA; Mailhos C; O'Reilly NJ; Ali RR; Coutelle C; George AJ; Harbottle RP; Knight AM; Larkin DF; Levinsky RJ; Seymour LW; Thrasher AJ; Kinnon C
Hum Gene Ther; 1998 Mar; 9(4):575-85. PubMed ID: 9525318
[TBL] [Abstract][Full Text] [Related]
8. Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells.
Wade-Martins R; Saeki Y; Chiocca EA
Mol Ther; 2003 May; 7(5 Pt 1):604-12. PubMed ID: 12718903
[TBL] [Abstract][Full Text] [Related]
9. Plasmid DNA size does affect nonviral gene delivery efficiency in stem cells.
Ribeiro S; Mairhofer J; Madeira C; Diogo MM; Lobato da Silva C; Monteiro G; Grabherr R; Cabral JM
Cell Reprogram; 2012 Apr; 14(2):130-7. PubMed ID: 22339198
[TBL] [Abstract][Full Text] [Related]
10. The incorporation of an ion channel gene mutation associated with the long QT syndrome (Q9E-hMiRP1) in a plasmid vector for site-specific arrhythmia gene therapy: in vitro and in vivo feasibility studies.
Burton DY; Song C; Fishbein I; Hazelwood S; Li Q; DeFelice S; Connolly JM; Perlstein I; Coulter DA; Levy RJ
Hum Gene Ther; 2003 Jun; 14(9):907-22. PubMed ID: 12828861
[TBL] [Abstract][Full Text] [Related]
11. Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature.
Young JL; Benoit JN; Dean DA
Gene Ther; 2003 Aug; 10(17):1465-70. PubMed ID: 12900761
[TBL] [Abstract][Full Text] [Related]
12. Formation of LID vector complexes in water alters physicochemical properties and enhances pulmonary gene expression in vivo.
Jenkins RG; Meng QH; Hodges RJ; Lee LK; Bottoms SE; Laurent GJ; Willis D; Ayazi Shamlou P; McAnulty RJ; Hart SL
Gene Ther; 2003 Jun; 10(12):1026-34. PubMed ID: 12776160
[TBL] [Abstract][Full Text] [Related]
13. Delivery and long-term expression of a 135 kb LDLR genomic DNA locus in vivo by hydrodynamic tail vein injection.
Hibbitt OC; Harbottle RP; Waddington SN; Bursill CA; Coutelle C; Channon KM; Wade-Martins R
J Gene Med; 2007 Jun; 9(6):488-97. PubMed ID: 17471590
[TBL] [Abstract][Full Text] [Related]
14. Infectious delivery of 120-kilobase genomic DNA by an epstein-barr virus amplicon vector.
White RE; Wade-Martins R; James MR
Mol Ther; 2002 Apr; 5(4):427-35. PubMed ID: 11945070
[TBL] [Abstract][Full Text] [Related]
15. Nonviral vector for efficient gene transfer to human ovarian adenocarcinoma cells.
Kim CK; Haider KH; Choi SH; Choi EJ; Ahn WS; Kim YB
Gynecol Oncol; 2002 Jan; 84(1):85-93. PubMed ID: 11748982
[TBL] [Abstract][Full Text] [Related]
16. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage.
Hanazono Y; Yu JM; Dunbar CE; Emmons RV
Hum Gene Ther; 1997 Jul; 8(11):1313-9. PubMed ID: 9295126
[TBL] [Abstract][Full Text] [Related]
17. A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA.
Schakowski F; Gorschlüter M; Junghans C; Schroff M; Buttgereit P; Ziske C; Schöttker B; König-Merediz SA; Sauerbruch T; Wittig B; Schmidt-Wolf IG
Mol Ther; 2001 May; 3(5 Pt 1):793-800. PubMed ID: 11356084
[TBL] [Abstract][Full Text] [Related]
18. Application to vascular adventitia of a nonviral vector for TIMP-1 gene therapy to prevent intimal hyperplasia.
Meng QH; Jamal W; Hart SL; McEwan JR
Hum Gene Ther; 2006 Jul; 17(7):717-27. PubMed ID: 16839271
[TBL] [Abstract][Full Text] [Related]
19. Optimization of non-viral gene transfer to human primary retinal pigment epithelial cells.
Abul-Hassan K; Walmsley R; Boulton M
Curr Eye Res; 2000 May; 20(5):361-6. PubMed ID: 10855030
[TBL] [Abstract][Full Text] [Related]
20. Optimization of a new non-viral vector for transfection: Eudragit nanoparticles for the delivery of a DNA plasmid.
Gargouri M; Sapin A; Bouli S; Becuwe P; Merlin JL; Maincent P
Technol Cancer Res Treat; 2009 Dec; 8(6):433-44. PubMed ID: 19925027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
